BWXT Reports Solid Second Quarter 2018 Results with Strong Revenue Growth
Highlights • 2Q18 strong revenue growth of 7%; 2Q18 orders up significantly • 2Q18 GAAP EPS of $0.60; 2Q18 non-GAAP EPS of $0.58 • Reiterated 2018 non-GAAP EPS guidance of $2.45 to $2.55 despite higher interest expense and integration costs • Completed acquisition of Nordion medical isotope business on July 30, 2018 View the full […]
BWXT Completes Acquisition of Sotera Health’s Nordion Medical Isotope Business
LYNCHBURG, Va. – BWX Technologies, Inc. (NYSE:BWXT) announced today that it has completed the acquisition of Sotera Health’s Nordion medical isotope business. The acquisition adds approximately 150 highly trained and experienced personnel, two specialized production centers and a uniquely licensed infrastructure that will de-risk BWXT’s entry into the medical radioisotope market. “We are extremely pleased […]
